NCT03995680View on ClinicalTrials.gov

Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm

PHASE2CompletedINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

July 12, 2019

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Hookworm Infections
Interventions
DRUG

Mebendazole

Treatment with one of the two formulations of mebendazole. The only difference between both arms is the type of formulation of the drug: chewable versus swallowable tablet.

Trial Locations (1)

Unknown

Public Health Laboratory Ivo de Carneri, Chake Chake

All Listed Sponsors
collaborator

Public Health Laboratory Ivo de Carneri

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER

NCT03995680 - Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm | Biotech Hunter | Biotech Hunter